Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia
| Autor: | K. Münstedt, Michael Pawlita, Ulrike Seifert, Marc Arbyn, Manfred Steiner, Klaus Friese, Lars Horn, Thomas Löning, Andreas M. Kaufmann, Thomas Iftner, Simone Wesselmann, K. Ulrich Petry, Hans Ikenberg, Stefanie J. Klug, M Jentschke, Anja Mehnert, Markus Follmann, Thomas Langer, Matthias W. Beckmann, Peter Hillemanns, M. Gebhardt, Michael Friedrich, Joachim Weis, Gaby Sroczynski, Dietmar Schmidt, Willi Sauerbrei, Juliane Hädicke, Uwe Siebert, Christoph Grimm, M.K. Fehr, Christian Dannecker, Olaf Reich, Achim Schneider, Axel Schäfer, Monika Nothacker, Jos Kleijnen, U. Freitag |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
HPV zervikale intraepitheliale Neoplasie (CIN) cervical cancer zervikale Präkanzerosen Guideline/Leitlinie cervical intraepithelial neoplasia (CIN) 03 medical and health sciences 0302 clinical medicine Maternity and Midwifery medicine cervical precancerous condition GebFra Science Opportunistic screening Cervix Cervical cancer 030219 obstetrics & reproductive medicine business.industry Obstetrics and Gynecology Cancer Zervixkarzinom Guideline medicine.disease medicine.anatomical_structure Systematic review Dysplasia Family medicine Professional association business |
| Zdroj: | Geburtshilfe und Frauenheilkunde |
| ISSN: | 0016-5751 |
| Popis: | Aims Annual opportunistic screening for cervical carcinoma has been carried out in Germany since 1971. The creation of this S3 guideline meets an important need, outlined in the National Cancer Plan, with regard to screening for cervical cancer, as the guideline aims to provide important information and support for planned organized screening for cervical cancer in Germany. Methods With the financial support of German Cancer Aid, 21 professional societies developed evidence-based statements and recommendations (classified using the GRADE system) for the screening, management and treatment of precancerous conditions of the cervix. Two independent scientific institutes compiled systematic reviews for this guideline. Recommendations The first part of this short summary presents the pathological basis and considers various questions related to screening for cervical cancer. As also reported in earlier reviews, the meta-analysis by Kleijnen Systematic Reviews showed that HPV-based screening offers better protection against invasive cervical cancer compared to cytology-based screening. The authors of this guideline therefore recommend – in accordance with the guideline of the Joint National Committee of Germany (Gemeinsamer Bundesauschuss, G-BA) – that women aged 35 and above should be examined at regular intervals (at least every 3 years) and undergo HPV-based screening. Co-testing can also be carried out. Women between the ages of 20 and 35 should have cytological screening every 2 years. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|